Use of Trehalose as an Additive to Bacteriophage Vb_Pd_PDCC-1: Long-Term Preservation Analysis and Its Biocontrol Against Vibrio diabolicus Infection

Phage therapy is a promising alternative to control bacterial diseases and the increasing problem of antibiotic resistance. In this sense, this research evaluates the viability of lyophilized vibrio phage vB_Pd_PDCC-1 using trehalose as a preservative excipient at different concentrations (4, 2, 1, and 0.5% w/v) and its potential for phage therapy application against a pathogenic bacteria Vibrio diabolicus in brine shrimp nauplii (Artemia franciscana). The lyophilized phages were stored at 4 and 23(degrees)C and rehydrated using biological sterile saline solution to test their viability at days 1, 15, and 60 post-lyophilization. The results showed that trehalose is beneficial in maintaining the viability of post-lyophilization phages (without titer losses) at 4 C-degrees and even at room temperature (23 C-degrees). When lyophilized phages with 4% w/v trehalose concentration were stored at 23 C-degrees, they had not titer losses among the trials; viability and titer concentration were maintained up to 60 days at log 7. The use of lyophilized phage PDCC-1 increased brine shrimp survival and reduced Vibrio concentrations. The present study has identified trehalose as a promising lyophilization excipient to effectively preserve lyophilized bacteriophages for biotechnological applications and long-term storage.

Automated summary

Phage therapy is a promising alternative to control bacterial diseases. This research evaluated the viability of lyophilized vibrio phage vB_Pd_PDCC-1 using trehalose as a preservative excipient. The results showed that trehalose is beneficial in maintaining the viability of post-lyophilization phages, even at room temperature. The use of lyophilized phage PDCC-1 increased brine shrimp survival and reduced Vibrio concentrations.